CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD)....
Phase 1
Barcelona, Spain and 17 other locations
is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney...
Phase 3
Barcelona, Spain and 17 other locations
The main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The...
Phase 2
Barcelona, Barcelona [Barcelona], Spain and 18 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
L'Hospitalet de Llobregat, Spain and 319 other locations
We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. W...
Phase 3
Barcelona, Spain and 32 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
L'Hospitalet de Llobregat, Spain and 295 other locations
The primary objective of this study is to evaluate the safety of tolvaptan in pediatric subjects with autosomal recessive polycystic kidney ...
Phase 3
Barcelona, Spain and 27 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
Hospitalet de Llobregat, Spain and 100 other locations
compared with dapagliflozin alone on patients with chronic kidney disease (CKD) and albuminuria. This study will evaluate the effec...
Phase 2
Barcelona, Spain and 116 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Barcelona, Spain and 338 other locations
Clinical trials
Research sites
Resources
Legal